A gastrointestinal stent for use in patients suffering GI obstructions from cancer has been cleared by the FDA, a Med City News report said.
The stent, called the Evolution Duodenal Controlled-Release Stent, will be available to use to combat gastric outlet obstruction as a result of advanced GI cancers. A European study found that 21 of 23 patients had "significant improvement" with the stent.
Related Articles about FDA Device Approvals:
GE's New MRI Machine Gets FDA Approval
FDA Forms Expert Panel to Speed up Device Approval
FDA Continuing Work to Improve Sound Development of Medical Products
The stent, called the Evolution Duodenal Controlled-Release Stent, will be available to use to combat gastric outlet obstruction as a result of advanced GI cancers. A European study found that 21 of 23 patients had "significant improvement" with the stent.
Related Articles about FDA Device Approvals:
GE's New MRI Machine Gets FDA Approval
FDA Forms Expert Panel to Speed up Device Approval
FDA Continuing Work to Improve Sound Development of Medical Products